To further evaluate the performance of GFRA1 methylation in predicting CRC invasion, ROC curves were initially calculated using probe sequence data with significantly reduced methylation levels (P<0.001) in lymphatic invasive tumors. This evidence concerns the gene GFRA1 and colorectal carcinoma.